Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. (Q48280138)

http://europepmc.org/abstract/MED/24899525

10 February 2018

title

Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. (English)

1 reference

http://europepmc.org/abstract/MED/24899525

10 February 2018

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tsuo-Hung Lan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Chin Cheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ching-Heng Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Yi-Wen Tsai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Chia-Jui Tsai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

4 June 2014

1 reference

http://europepmc.org/abstract/MED/24899525

10 February 2018

published in

The Journals of Gerontology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1299-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2FGLU073

21 January 2018

Identifiers

DOI

10.1093/GERONA/GLU073

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24899525%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference